Skip to content

Dental Plaque Prevention Efficacy of a Stannous Fluoride Toothpaste

Dental Plaque Prevention Efficacy Evaluation and Comparison of a Stannous Fluoride Toothpaste

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07419737
Enrollment
91
Registered
2026-02-19
Start date
2024-10-16
Completion date
2024-12-04
Last updated
2026-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Plaque

Brief summary

This randomized, stratified, double-blind, two-cell parallel clinical study evaluated the dental plaque prevention efficacy of a stannous fluoride toothpaste compared to a sodium fluoride control toothpaste following a professional dental prophylaxis. Adult subjects brushed twice daily for 14 days with their assigned dentifrice. Plaque was assessed using the Lobene-Soparkar modification of the Turesky Modification of the Quigley-Hein Plaque Index at baseline, Day 1, and Day 14 following periods of oral hygiene abstention.

Detailed description

This two-week, randomized, double-blind, parallel-group study evaluated plaque prevention following dental cleaning. Subjects meeting plaque qualification criteria underwent a complete prophylaxis and were randomized to either a stannous fluoride test dentifrice or a sodium fluoride control dentifrice. Subjects brushed twice daily for two minutes with the assigned product. Plaque accumulation was assessed at baseline, after one day of use, and after 14 days of use following overnight abstention from oral hygiene. Plaque was disclosed and scored on facial and lingual tooth surfaces using the Lobene-Soparkar modified Turesky Plaque Index. Treatment comparisons were performed using ANCOVA with baseline plaque as a covariate.

Interventions

Test toothpaste (0.454% SnF)

Comparator toothpaste (0.243% NaF)

Sponsors

Church & Dwight Company, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* Good general health based on medical history * Minimum of 18 natural teeth with scorable surfaces * Baseline mean plaque score ≥2.0 * Willing to refrain from non-study oral hygiene products * Willing to abstain from oral hygiene prior to study visits * Able and willing to comply with study procedures

Exclusion criteria

* Known allergy to oral care products * Conditions limiting normal brushing * Significant medical conditions affecting study participation * Pregnant or nursing females * Severe periodontal disease * Recent dental prophylaxis * Recent participation in another dental study

Design outcomes

Primary

MeasureTime frameDescription
Whole-Mouth Dental Plaque Score (Turesky Modified Quigley-Hein Index)Day 14 (12 hours post-brushing following 14 days of twice-daily use)Mean whole-mouth plaque index score assessed using the Lobene-Soparkar modification of the Turesky Modification of the Quigley-Hein Plaque Index. Treatment comparisons performed using ANCOVA with baseline plaque score as a covariate.

Secondary

MeasureTime frameDescription
Whole-Mouth Dental Plaque Score at Day 1Day 1 (12 hours post-brushing)Mean whole-mouth plaque index score assessed one day after initial supervised brushing.

Countries

United States

Contacts

STUDY_DIRECTORAnnahita Ghassemi, PhD

Church & Dwight, Inc.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026